RG
ASPX

Redmile Group’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Redmile Group’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-417,533
Closed -$41.9M – 67
2015
Q1 		$41.9M Buy
+417,533
New +$27.8M 3.76% 7

Redmile Group's ASPX Position: Q2 2015 in Review

Redmile Group sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 417,533 shares — an estimated $41.9M sold.

Redmile Group first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $41.9M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Redmile Group reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Redmile Group sold 417,533 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $41.9M.
  • Redmile Group first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Redmile Group's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $41.9M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Redmile Group's 13F filing for Q2 2015, filed 14 Aug 2015.